Collagen XVII: A shared antigen in neurodermatological interactions?

Clinical and Developmental Immunology

Volumn 2013, Issue , 2013, Pages

  Seppänen, Allan ^a  

^a VANHA VAASA HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 17; ANTIGEN; AUTOANTIGEN; NONFIBRILLAR COLLAGEN;

BLOOD VESSEL PERMEABILITY; BULLOUS PEMPHIGOID; CEREBROVASCULAR ACCIDENT; CHEMICAL STRUCTURE; COGNITIVE DEFECT; DEMENTIA; EPIDERMOLYSIS BULLOSA; EPILEPSY; HUMAN; MUCOUS MEMBRANE PEMPHIGOID; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN STRUCTURE; REVIEW; SCHIZOPHRENIA; SKIN DISEASE; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION; ANIMAL; GENE EXPRESSION; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; PROTEIN CONFORMATION;

ANIMALS; ANTIGENS; AUTOANTIGENS; GENE EXPRESSION; HUMANS; NERVOUS SYSTEM DISEASES; NON-FIBRILLAR COLLAGENS; PEMPHIGOID, BULLOUS; PROTEIN CONFORMATION;

EID: 84880173895     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2013/240570     Document Type: Review

References (89)

1. Myllyharju J., Kivirikko K. I., Collagens, modifying enzymes and their mutations in humans, flies and worms. Trends in Genetics 2004 20 1 33 43 2-s2.0-0347418197 10.1016/j.tig.2003.11.004
2. Kadler K. E., Baldock C., Bella J., Boot-Handford R. P., Collagens at a glance. Journal of Cell Science 2007 120 part 12 1955 1958 2-s2.0-34347340677 10.1242/jcs.03453
3. Sajanti J., Björkstrand A.-S., Finnilä S., Heikkinen E., Peltonen J., Majamaa K., Increase of collagen synthesis and deposition in the arachnoid and the dura following subarachnoid hemorrhage in the rat. Biochimica et Biophysica Acta 1999 1454 3 209 216 2-s2.0-0345035351 10.1016/S0925-4439(99) 00016-2
4. Cardoso F. L., Brites D., Brito M. A., Looking at the blood-brain barrier: molecular anatomy and possible investigation approaches. Brain Research Reviews 2010 64 2 328 363 2-s2.0-77956344034 10.1016/j.brainresrev.2010.05.003
5. Fox M. A., Novel roles for collagens in wiring the vertebrate nervous system. Current Opinion in Cell Biology 2008 20 5 508 513 2-s2.0-50849107027 10.1016/j.ceb.2008.05.003
6. Hubert T., Grimal S., Carroll P., Fichard-Carroll A., Collagens in the developing and diseased nervous system. Cellular and Molecular Life Sciences 2009 66 7 1223 1238 2-s2.0-63449110524 10.1007/s00018-008-8561-9
7. Sertié A. L., Sossi V., Camargo A. A., Zatz M., Brahe C., Passos-Bueno M. R., Collagen XVIII, containing an endogenous inhibitor of angiogenesis and tumor growth, plays a critical role in the maintenance of retinal structure and in neural tube closure (Knobloch syndrome). Human Molecular Genetics 2000 9 13 2051 2058 2-s2.0-0034641597
8. Ali S. A., Pappas I. S., Parnavelas J. G., Collagen type IV promotes the differentiation of neuronal progenitors and inhibits astroglial differentiation in cortical cell cultures. Developmental Brain Research 1998 110 1 31 38 2-s2.0-0032505050 10.1016/S0165-3806(98)00091-1
9. Schneider V. A., Granato M., The myotomal diwanka (lh3) glycosyltransferase and type XVIII collagen are critical for motor growth cone migration. Neuron 2006 50 5 683 695 2-s2.0-33646848764 10.1016/j.neuron.2006.04. 024
10. Xiao T., Baier H., Lamina-specific axonal projections in the zebrafish tectum require the type IV collagen Dragnet. Nature Neuroscience 2007 10 12 1529 1537 2-s2.0-36448939820 10.1038/nn2002
11. Fox M. A., Sanes J. R., Borza D.-B., Eswarakumar V. P., Fässler R., Hudson B. G., John S. W. M., Ninomiya Y., Pedchenko V., Pfaff S. L., Rheault M., Sado Y., Segal Y., Werle M. J., Umemori H., Distinct target-derived signals organize formation, maturation, and maintenance of motor nerve terminals. Cell 2007 129 1 179 193 2-s2.0-33947723874 10.1016/j.cell.2007.02.035
12. Heffron D. S., Landreth G. E., Samuels I. S., Mandell J. W., Brain-specific deletion of extracellular signal-regulated kinase 2 mitogen-activated protein kinase leads to aberrant cortical collagen deposition. American Journal of Pathology 2009 175 6 2586 2599 2-s2.0-73549104287 10.2353/ajpath.2009.090130
13. Hooper N. M., Karran E. H., Turner A. J., Membrane protein secretases. Biochemical Journal 1997 321 part 2 265 279 2-s2.0-0031032891
14. Franzke C.-W., Tasanen K., Schumann H., Bruckner-Tuderman L., Collagenous transmembrane proteins: collagen XVII as a prototype. Matrix Biology 2003 22 4 299 309 2-s2.0-0042664095 10.1016/S0945-053X(03)00051-9
15. Franzke C.-W., Bruckner P., Bruckner-Tuderman L., Collagenous transmembrane proteins: recent insights into biology and pathology. Journal of Biological Chemistry 2005 280 6 4005 4008 2-s2.0-14244264636 10.1074/jbc.R400034200
16. Giudice G. J., Emery D. J., Diaz L. A., Cloning and primary structural analysis of the bullous pemphigoid autoantigen BP180. Journal of Investigative Dermatology 1992 99 3 243 250 2-s2.0-0026726355
17. Hopkinson S. B., Findlay K., DeHart G. W., Jones J. C. R., Interaction of BP180 (type XVII collagen) and CC6 integrin is necessary for stabilization of hemidesmosome structure. Journal of Investigative Dermatology 1998 111 6 1015 1022 2-s2.0-0032447962
18. Hopkinson S. B., Jones J. C. R., The N terminus of the transmembrane protein BP180 interacts with the N- terminal domain of BP230, thereby mediating keratin cytoskeleton anchorage to the cell surface at the site of the hemidesmosome. Molecular Biology of the Cell 2000 11 1 277 286 2-s2.0-0033973133
19. Hopkinson S. B., Baker S. E., Jones J. C. R., Molecular genetic studies of a human epidermal autoantigen (the 180-kD bullous pemphigoid antigen/BP180): identification of functionally important sequences within the BP180 molecule and evidence for an interaction between BP180 and α 6 integrin. Journal of Cell Biology 1995 130 1 117 125 2-s2.0-0029005210 10.1083/jcb.130.1.117
20. Franzke C.-W., Bruckner-Tuderman L., Blobel C. P., Shedding of collagen XVII/BP180 in skin depends on both ADAM10 and ADAM9. Journal of Biological Chemistry 2009 284 35 23386 23396 2-s2.0-69949153341 10.1074/jbc.M109.034090
21. Franzke C.-W., Tasanen K., Schäcke H., Zhou Z., Tryggvason K., Mauch C., Zigrino P., Sunnarborg S., Lee D. C., Fahrenholz F., Bruckner-Tuderman L., Transmembrane collagen XVII, an epithelial adhesion protein, is shed from the cell surface by ADAMS. EMBO Journal 2002 21 19 5026 5035 2-s2.0-18644384411 10.1093/emboj/cdf532
22. Schäcke H., Schumann H., Hammami-Hauasli N., Raghunath M., Bruckner-Tuderman L., Two forms of collagen XVII in keratinocytes: a full-length transmembrane protein and a soluble ectodomain. Journal of Biological Chemistry 1998 273 40 25937 25943 2-s2.0-0032476013 10.1074/jbc.273.40.25937
23. Tasanen K., Tunggal L., Chometon G., Bruckner-Tuderman L., Aumailley M., Keratinocytes from patients lacking collagen XVII display a migratory phenotype. American Journal of Pathology 2004 164 6 2027 2038 2-s2.0-2442701762
24. Claudepierre T., Manglapus M. K., Marengi N., Radner S., Champliaud M.-F., Tasanen K., Bruckner-Tuderman L., Hunter D. D., Brunken W. J., Collagen XVII and BP AG1 expression in the retina: evidence for an anchoring complex in the central nervous system. Journal of Comparative Neurology 2005 487 2 190 203 2-s2.0-19544394260 10.1002/cne.20549
25. Seppänen A., Autio-Harmainen H., Alafuzoff I., Särkioja T., Veijola J., Hurskainen T., Bruckner-Tuderman L., Tasanen K., Majamaa K., Collagen XVII is expressed in human CNS neurons. Matrix Biology 2006 25 3 185 188 2-s2.0-33645415000 10.1016/j.matbio.2005.11.004
26. Seppänen A., Suuronen T., Hofmann S. C., Majamaa K., Alafuzoff I., Distribution of collagen XVII in the human brain. Brain Research 2007 1158 1 50 56 2-s2.0-34447520444 10.1016/j.brainres.2007.04.073
27. Seppänen A., Miettinen R., Alafuzoff I., Neuronal collagen XVII is localized to lipofuscin granules. NeuroReport 2010 21 17 1090 1094 2-s2.0-78349308683 10.1097/WNR.0b013e3283405352
28. Powell A. M., Sakuma-Oyama Y., Oyama N., Black M. M., Collagen XVII/BP180: a collagenous transmembrane protein and component of the dermoepidermal anchoring complex. Clinical and Experimental Dermatology 2005 30 6 682 687 2-s2.0-27144489971 10.1111/j.1365-2230.2005.01937.x
29. Kasperkiewicz M., Zillikens D., Schmidt E., Pemphigoid diseases: pathogenesis, diagnosis, and treatment. Autoimmunity 2012 45 1 55 70 2-s2.0-84856421317 10.3109/08916934.2011.606447
30. Liu Z., Diaz L. A., Troy J. L., Taylor A. F., Emery D. J., Fairley J. A., Giudice G. J., A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180. Journal of Clinical Investigation 1993 92 5 2480 2488 2-s2.0-0027520703
31. Huilaja L., Makikallo K., Sormunen R., Lohi J., Hurskainen T., Tasanen K., Gestational pemphigoid: placental morphology and function. Acta Dermato-Venereologica 2013 93 1 33 38
32. Zillikens D., Rose P. A., Balding S. D., Liu Z., Olague-Marchan M., Diaz L. A., Giudice G. J., Tight clustering of extracellular BP180 epitopes recognized by bullous pemphigoid autoantibodies. Journal of Investigative Dermatology 1997 109 4 573 579 2-s2.0-0030879947
33. Leighty L., Li N., Diaz L. A., Liu Z., Experimental models for the autoimmune and inflammatory blistering disease, Bullous pemphigoid. Archives of Dermatological Research 2007 299 9 417 422 2-s2.0-35148878300 10.1007/s00403-007-0790-5
34. Kasperkiewicz M., Zillikens D., The pathophysiology of bullous pemphigoid. Clinical Reviews in Allergy and Immunology 2007 33 1-2 67 77 2-s2.0-39649094566 10.1007/s12016-007-0030-y
35. Cortés B., Marazza G., Naldi L., Combescure C., Borradori L., Mortality of bullous pemphigoid in Switzerland: a prospective study. British Journal of Dermatology 2011 165 2 368 374 2-s2.0-79960621960 10.1111/j.1365-2133.2011.10413.x
36. Foureur N., Descamps V., Lebrun-Vignes B., Picard-Dahan C., Belaich M., Crickx S., Grossin B., Bullous pemphigoid in a leg affected with hemiparesia: a possible relation of neurological diseases with bullous pemphigoid? European Journal of Dermatology 2001 11 3 230 233 2-s2.0-0035013903
37. Cordel N., Chosidow O., Hellot M.-F., Delaporte E., Lok C., Vaillant L., Bernard P., D'Incan M., Roujeau J. C., Joly P., Neurological disorders in patients with bullous pemphigoid. Dermatology 2007 215 3 187 191 2-s2.0-34548496643 10.1159/000106574
38. Jedlickova H., Hlubinka M., Pavlik T., Semradova V., Budinska E., Vlasin Z., Bullous pemphigoid and internal diseases-a case-control study. European Journal of Dermatology 2010 20 1 96 101 2-s2.0-76749163649 10.1684/ejd.2010.0805
39. Taghipour K., Chi C.-C., Vincent A., Groves R. W., Venning V., Wojnarowska F., The association of bullous pemphigoid with cerebrovascular disease and dementia: a case-control study. Archives of Dermatology 2010 146 11 1251 1254 2-s2.0-78349285978 10.1001/archdermatol.2010.322
40. Langan S. M., Groves R. W., West J., The relationship between neurological disease and bullous pemphigoid: a population-based case-control study. Journal of Investigative Dermatology 2011 131 3 631 636 2-s2.0-79951512187 10.1038/jid.2010.357
41. Bastuji-Garin S., Joly P., Lemordant P., Sparsa A., Bedane C., Delaporte E., Roujeau J.-C., Bernard P., Guillaume J.-C., Ingen-Housz-Oro S., Maillard H., Pauwels C., Picard-Dahan C., Dutronc Y., Richard M.-A., Risk factors for bullous pemphigoid in the elderly: a prospective case-control study. Journal of Investigative Dermatology 2011 131 3 637 643 2-s2.0-79951511421 10.1038/jid.2010.301
42. Chen Y. J., Wu C. Y., Lin M. W., Chen T. J., Liao K. K., Chen Y. C., Hwang C. Y., Chu S. Y., Chen C. C., Lee D. D., Chang Y. T., Wang W. J., Liu H. N., Comorbidity profiles among patients with bullous pemphigoid: a nationwide population-based study. British Journal of Dermatology 2011 165 3 593 599 2-s2.0-80052270958 10.1111/j.1365-2133.2011.10386.x
43. Kanda N., Soga Y., Meguro M., Tanabe A., Yagi Y., Himuro Y., Fujiwara Y., Takashiba S., Kobayashi N., Discovery of a patient with strongly suspected bullous pemphigoid in a ward by oral health care providers. International journal of dental hygiene 2011 9 2 159 162 2-s2.0-80052096657 10.1111/j.1601-5037.2010.00448.x
44. Foureur N., Mignot S., Senet P., Verpillat P., Picard-Dahan C., Crickx B., Labarre C., Nicaise-Roland P., Descamps V., Correlation between the presence of type-2 anti-pemphigoid antibodies and dementia in elderly subjects with no clinical signs of pemphigoid. Annales de Dermatologie et de Venereologie 2006 133 5, part 1 439 443 2-s2.0-33747674317
45. Stinco G., Codutti R., Scarbolo M., Valent F., Patrone P., A retrospective epidemiological study on the association of bullous pemphigoid and neurological diseases. Acta Dermato-Venereologica 2005 85 2 136 139 2-s2.0-16444387306 10.1080/00015550410024481
46. Stinco G., Mattighello P., Zanchi M., Patrone P., Multiple sclerosis and bullous pemphigoid: a casual association or a pathogenetic correlation? European Journal of Dermatology 2002 12 2 186 188 2-s2.0-0036188316
47. Kirtschig G., Walkden V. M., Venning V. A., Wojnarowska F., Bullous pemphigoid and multiple sclerosis: a report of three cases and review of the literature. Clinical and Experimental Dermatology 1995 20 6 449 453 2-s2.0-0029550074 10.1111/j.1365-2230.1995.tb01375.x
48. Simjee S., Konqui A., Ahmed A. R., Multiple sclerosis and bullous pemphigoid. Dermatologica 1985 170 2 86 89 2-s2.0-0021963693
49. Forschner A., Ulmer A., Rassner G., Fierlbeck G., Bullous pemphigoid in a patient with Parkinson's disease. European Journal of Dermatology 2002 12 6 615 2-s2.0-0036861603
50. Long C. C., Lever L. R., Marks R., Unilateral bullous pemphigoid in a hemiplegic patient. British Journal of Dermatology 1992 126 6 614 616 2-s2.0-0026773864
51. Bunker C. B., Brown E., Unilateral bullous pemphigoid in a hemiplegic patient. British Journal of Dermatology 1993 129 4 502 2-s2.0-0027518227
52. Wijeratne C., Webster P., Risperidone bullous pemphigoid. American Journal of Psychiatry 1996 153 5 735 2-s2.0-0029897977
53. Bastuji-Garin S., Joly P., Picard-Dahan C., Bernard P., Vaillant L., Pauwels C., Salagnac V., Lok C., Roujeau J.-C., Drugs associated with bullous pemphigoid: a case-control study. Archives of Dermatology 1996 132 3 272 276 2-s2.0-0029865652 10.1001/archderm.132.3.272
54. Bourdon-Lanoy E., Roujeau J.-C., Joly P., Guillaume J.-C., Bernard P., Prost C., Tancrède-Bohin E., Delaporte E., Picard-Dahan C., Albes B., Bedane C., Doutre M.-S., Chosidow O., Lok C., Pauwels C., Chevrand-Breton J., Sassolas B., Richard M.-A., Bullous pemphigoid in young patients: a retrospective study of 74 cases. Annales de Dermatologie et de Venereologie 2005 132 2 115 122 2-s2.0-20144374922
55. Pfendner G., Lucky A., Pagon R., Bird T., Dolan C., Junctional epidermolysis bullosa. GeneReviews 2008 Seattle, Wash, USA University of Washington
56. Van den Bergh F., Eliason S. L., Burmeister B. T., Giudice G. J., Collagen XVII (BP180) modulates keratinocyte expression of the proinflammatory chemokine, IL-8. Experimental Dermatology 2012 21 605 611
57. Li L., Chen J., Wang B., Yao Y., Zuo Y., Sera from patients with bullous pemphigoid (BP) associated with neurological diseases recognized BP antigen 1 in the skin and brain. British Journal of Dermatology 2009 160 6 1343 1345 2-s2.0-66149130344 10.1111/j.1365-2133.2009.09122.x
58. Laffitte E., Burkhard P. R., Fontao L., Jaunin F., Saurat J.-H., Chofflon M., Borradori L., Bullous pemphigoid antigen 1 isoforms: potential new target autoantigens in multiple sclerosis? British Journal of Dermatology 2005 152 3 537 540 2-s2.0-17444381948 10.1111/j.1365-2133.2004.06338.x
59. García-Estévez D. A., Peón-Currás G., Bal-Nieves F., Bullous pemphigoid and amyotrophic lateral sclerosis. Revista de Neurologia 2008 47 10 525 526 2-s2.0-57049084597
60. Chen J., Li L., Chen J., Zeng Y., Xu H., Song Y., Wang B., Sera of elderly bullous pemphigoid patients with associated neurological diseases recognize bullous pemphigoid antigens in the human brain. Gerontology 2011 57 3 211 216 2-s2.0-79955463720 10.1159/000315393
61. Taghipour K., Chi C. C., Bhogal B., Groves R. W., Venning V., Wojnarowska F., Immunopathological characteristics of patients with bullous pemphigoid and neurological disease. Journal of the European Academy of Dermatology and Venereology 2013 10.1111/jdv.12136
62. Taghipour K., Kirtschig G., Palace J., Groves R. W., Venning V., Wojnarowska F., The association of multiple sclerosis with bullous pemphigoid: is there a shared antigen response? Journal of the American Academy of Dermatology 2012 67 1 160 161
63. Wieland C. N., Comfere N. I., Gibson L. E., Weaver A. L., Krause P. K., Murray J. A., Anti-bullous pemphigoid 180 and 230 antibodies in a sample of unaffected subjects. Archives of Dermatology 2010 146 1 21 25 2-s2.0-74549201112 10.1001/archdermatol.2009.331
64. Foureur N., Grootenboer-Mignot S., Descamps V., Value of the detection of circulating antibodies against BP antigens in unaffected subjects. Archives of Dermatology 2010 146 7 801 2-s2.0-77954821702
65. Soni A., Irani S. R., Lang B., Taghipour K., Mann R., Vincent A., Collins D., Immunotherapy: responsive autoimmune encephalopathy associated with bullous pemphigoid. Journal of Neurology, Neurosurgery and Psychiatry 2009 80 12 1412 1413 2-s2.0-72449134420 10.1136/jnnp.2008.165894
66. Bouras C., Riederer B. M., Kövari E., Hof P. R., Giannakopoulos P., Humoral immunity in brain aging and Alzheimer's disease. Brain Research Reviews 2005 48 3 477 487 2-s2.0-19544384207 10.1016/j.brainresrev.2004.09.009
67. Zeevi N., Pachter J., McCullough L. D., Wolfson L., Kuchel G. A., The blood-brain barrier: geriatric relevance of a critical brain-body interface. Journal of the American Geriatrics Society 2010 58 9 1749 1757 2-s2.0-77956326640 10.1111/j.1532-5415.2010.03011.x
68. Pelegrí C., Canudas A. M., del Valle J., Casadesus G., Smith M. A., Camins A., Pallàs M., Vilaplana J., Increased permeability of blood-brain barrier on the hippocampus of a murine model of senescence. Mechanisms of Ageing and Development 2007 128 9 522 528 2-s2.0-34548305271 10.1016/j.mad.2007.07.002
69. Barnes J., Bartlett J. W., van de Pol L. A., Loy C. T., Scahill R. I., Frost C., Thompson P., Fox N. C., A meta-analysis of hippocampal atrophy rates in Alzheimer's disease. Neurobiology of Aging 2009 30 11 1711 1723 2-s2.0-66249125569 10.1016/j.neurobiolaging.2008.01.010
70. Perry G., Castellani R. J., Hirai K., Smith M. A., Reactive oxygen species mediate cellular damage in Alzheimer disease. Journal of Alzheimer's Disease 1998 1 1 45 55 2-s2.0-0032229327
71. Terman A., Brunk U. T., Oxidative stress, accumulation of biological 'garbage', and aging. Antioxidants and Redox Signaling 2006 8 1-2 197 204 2-s2.0-33644641768 10.1089/ars.2006.8.197
72. Seehafer S. S., Pearce D. A., You say lipofuscin, we say ceroid: defining autofluorescent storage material. Neurobiology of Aging 2006 27 4 576 588 2-s2.0-33344469599 10.1016/j.neurobiolaging.2005.12.006
73. Brunk U. T., Terman A., Lipofuscin: mechanisms of age-related accumulation and influence on cell function. Free Radical Biology and Medicine 2002 33 5 611 619 2-s2.0-0036710928 10.1016/S0891-5849(02)00959-0
74. Zhu X., Castellani R. J., Moreira P. I., Aliev G., Shenk J. C., Siedlak S. L., Harris P. L. R., Fujioka H., Sayre L. M., Szweda P. A., Szweda L. I., Smith M. A., Perry G., Hydroxynonenal-generated crosslinking fluorophore accumulation in Alzheimer disease reveals a dichotomy of protein turnover. Free Radical Biology and Medicine 2012 52 3 699 704 2-s2.0-84856283539 10.1016/j.freeradbiomed.2011.11.004
75. Stojanovic A., Roher A. E., Ball M. J., Quantitative analysis of lipofuscin and neurofibrillary tangles in the hippocampal neurons of Alzheimer disease brains. Dementia 1994 5 5 229 233 2-s2.0-0028037679
76. Yang Y.-W., Chen Y.-H., Xirasagar S., Lin H.-C., Increased risk of stroke in patients with bullous pemphigoid: a population-based follow-up study. Stroke 2011 42 2 319 323 2-s2.0-79251620328 10.1161/STROKEAHA.110.596361
77. Ameglio F., D'Auria L., Cordiali-Fei P., Mussi A., Valenzano L., D'Agosto G., Ferraro C., Bonifati C., Giacalone B., Bullous pemphigoid and pemphigus vulgaris: correlated behaviour of serum VEGF, sE-selectin and TNF-alpha levels. Journal of Biological Regulators and Homeostatic Agents 1997 11 4 148 153 2-s2.0-0031432387
78. Ross R., Dodet B., Atherosclerosis is an inflammatory disease. American Heart Journal 1999 138 5, part 2 S419 S420 2-s2.0-0032693599
79. Marzano A. V., Tedeschi A., Berti E., Fanoni D., Crosti C., Cugno M., Activation of coagulation in bullous pemphigoid and other eosinophil-related inflammatory skin diseases. Clinical and Experimental Immunology 2011 165 1 44 50 2-s2.0-79958144456 10.1111/j.1365-2249.2011.04391.x
80. Moosbauer C., Morgenstern E., Cuvelier S. L., Manukyan D., Bidzhekov K., Albrecht S., Lohse P., Patel K. D., Engelmann B., Eosinophils are a major intravascular location for tissue factor storage and exposure. Blood 2007 109 3 995 1002 2-s2.0-33846859336 10.1182/blood-2006-02-004945
81. Marzano A. V., Tedeschi A., Fanoni D., Bonanni E., Venegoni L., Berti E., Cugno M., Activation of blood coagulation in bullous pemphigoid: role of eosinophils, and local and systemic implications. British Journal of Dermatology 2009 160 2 266 272 2-s2.0-58349119143 10.1111/j.1365-2133.2008.08880.x
82. Echigo T., Hasegawa M., Inaoki M., Yamazaki M., Sato S., Takehara K., Antiphospholipid antibodies in patients with autoimmune blistering disease. Journal of the American Academy of Dermatology 2007 57 3 397 400 2-s2.0-34547804701 10.1016/j.jaad.2006.07.004
83. Konradi C., Sillivan S. E., Clay H. B., Mitochondria, oligodendrocytes and inflammation in bipolar disorder: evidence from transcriptome studies points to intriguing parallels with multiple sclerosis. Neurobiology of Disease 2012 45 1 37 47 2-s2.0-81955161265 10.1016/j.nbd.2011.01.025
84. Arion D., Unger T., Lewis D. A., Levitt P., Mirnics K., Molecular Evidence for Increased Expression of Genes Related to Immune and Chaperone Function in the Prefrontal Cortex in Schizophrenia. Biological Psychiatry 2007 62 7 711 721 2-s2.0-34548499635 10.1016/j.biopsych.2006.12.021
85. Lennox B. R., Coles A. J., Vincent A., Antibody-mediated encephalitis: a treatable cause of schizophrenia. British Journal of Psychiatry 2012 200 2 92 94 2-s2.0-84857099397 10.1192/bjp.bp.111.095042
86. Steiner J., Walter M., Glanz W., Increased prevalence of diverse N -Methyl-D-Aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N -Methyl-D-Aspartate glutamate receptor encephalitis. JAMA Psychiatry 2013 70 3 271 278
87. Pandey R. S., Gupta A. K., Chaturvedi U. C., Autoimmune model of schizophrenia with special reference to antibrain antibodies. Biological Psychiatry 1981 16 12 1123 1136 2-s2.0-0019802399
88. Ganguli R., Brar J. S., Chengappa K. N. R., Yang Z. W., Nimgaonkar V. L., Rabin B. S., Autoimmunity in schizophrenia: a review of recent findings. Annals of Medicine 1993 25 5 489 496 2-s2.0-0027493098
89. Goldstein B. I., Kemp D. E., Soczynska J. K., McIntyre R. S., Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature. Journal of Clinical Psychiatry 2009 70 8 1078 1090 2-s2.0-70349562518 10.4088/JCP.08r04505